ADC Therapeutics (ADCT) Interest Coverage Ratio (2020 - 2026)
ADC Therapeutics (ADCT) posted Interest Coverage Ratio of 2.04 for Q1 2026, up 11.6% sequentially from 2.31 in Q3 2025, and up 12.16% YoY from 1.82 in Q1 2025.
ADC Therapeutics (ADCT) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
ADC Therapeutics has reported Interest Coverage Ratio for 7 years, with the latest figure at 2.04 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 12.16% year-over-year to 2.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.83 (down 191.33% YoY) and the FY2022 annual result came in at 0.16, up 98.59% from the prior year.
- Interest Coverage Ratio improved to 2.04 in Q1 2026 per ADCT's latest filing, from 2.31 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.27 in Q3 2022 and troughed at 7.89 in Q2 2022.
- A 5-year average of 3.32 and a median of 2.77 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio surged 97.98% in 2022, then tumbled 928.61% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 4.58 in 2022, then surged by 38.4% to 2.82 in 2023, then advanced by 3.88% to 2.71 in 2024, then climbed by 14.71% to 2.31 in 2025, then rose by 11.6% to 2.04 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.04, 2.31, and 3.4 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - | 1.42 |
| 10 | ADC Therapeutics | 152.61 Mn | -66.49 Mn | 17.14 Mn | -1.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.88 |
| Mar 31, 2026 | -2.04 |
| Sep 30, 2025 | -2.31 |
| Jun 30, 2025 | -3.40 |
| Mar 31, 2025 | -2.33 |
| Sep 30, 2024 | -2.71 |
| Jun 30, 2024 | -2.29 |
| Mar 31, 2024 | -2.69 |
| Sep 30, 2023 | -2.82 |
| Jun 30, 2023 | -3.85 |
| Mar 31, 2023 | -4.95 |
| Dec 31, 2022 | -4.58 |
| Sep 30, 2022 | -0.27 |
| Jun 30, 2022 | -7.89 |
| Mar 31, 2022 | -4.38 |
| Dec 31, 2021 | -2.73 |
| Sep 30, 2021 | -13.55 |
| Jun 30, 2021 | -27.59 |
| Mar 31, 2021 | -31.85 |
| Dec 31, 2020 | -26.48 |